Gastrointestinal Cancers: Managed Care Strategies to Improve Resource Utilization With Immune Checkpoint Inhibitors
This virtual symposium will explain the influence biomarker testing assays have on the overall cost of drug therapy for patients with gastrointestinal (GI) cancer who are receiving treatment with an immune checkpoint inhibitor.
The Expanding Treatment Landscape of Inflammatory Bowel Disease: The Role of the Specialty Pharmacist
The activity will explore specialty pharmacy operational and clinical practices that have the greatest potential to improve outcomes for patients with IBD.
The Evolution of Immune Checkpoint Inhibitors in the Treatment of GI Cancers and the Pharmacist's Growing Role
This activity will review biomarkers useful for predicting patient response to immune checkpoint inhibitors and techniques for adherence monitoring will also be addressed to assist pharmacists in developing strategies to optimize the care and management of patients with GI cancers.
Hereditary Angioedema: Outlining the Differences Between Current and Emerging Therapies
This activity will equip pharmacists with the knowledge necessary to educate and counsel patients on appropriate medication use for effective and safe management of HAE attacks.